Immunovant, Inc. (IMVT)
NASDAQ·Healthcare·Biotechnology
$30.53
+7.33%
Mkt Cap $6.31B
Analyst Ratings
Buy
5
Hold
1
Sell
0
Price Target (10 analysts)
$40.00
Range $40.00 – $40.00
Implied Upside
+31.0%
Consensus $40.00 vs current $30.53
NASDAQ·Healthcare·Biotechnology
$30.53
+7.33%
Mkt Cap $6.31B
Buy
5
Hold
1
Sell
0
Price Target (10 analysts)
$40.00
Range $40.00 – $40.00
+31.0%
Consensus $40.00 vs current $30.53